Tagworks Pharmaceuticals anuncia el inicio del ensayo clínico de fase 0/1 para TGW211 ...Middle East

- Tagworks Pharmaceuticals anuncia la autorización de la CTA y el inicio del ensayo clínico de fase 0/1 para TGW211, un radiofármaco para el tratamiento de tumores HER2+ TGW211 es un radioinmunoconjugado dirigido a HER2 de última generación, el primero en su clase, desarrollado con base...

Hence then, the article about tagworks pharmaceuticals anuncia el inicio del ensayo clinico de fase 0 1 para tgw211 was published today ( Thursday 16/10/2025 - 06:11 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Tagworks Pharmaceuticals anuncia el inicio del ensayo clínico de fase 0/1 para TGW211 )

Also on site :

• How Assad’s Top Henchmen Fled Syria and Justice
• Numbrix 9 - October 16
• Ukrainian soldiers busted over torture spree – police